TGF-beta/SMAD Pathway and Its Regulation in Hepatic Fibrosis.
Xu F, Liu C, Zhou D, Zhang L.
J Histochem Cytochem. 2016 Mar;64(3):157-67. doi: 10.1369/0022155415627681. Epub 2016 Jan 8.
Hepatic fibrosis 2022: Unmet needs and a blueprint for the future.
Friedman SL, Pinzani M.
Hepatology. 2022 Feb;75(2):473-488. doi: 10.1002/hep.32285. Epub 2022 Jan 11.
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Khanam A, Saleeb PG, Kottilil S.
Cells. 2021 May 4;10(5):1097. doi: 10.3390/cells10051097.
Hepatic Fibrosis in Dogs.
Eulenberg VM, Lidbury JA.
J Vet Intern Med. 2018 Jan;32(1):26-41. doi: 10.1111/jvim.14891. Epub 2017 Nov 30.
Key Players of Hepatic Fibrosis.
Dawood RM, El-Meguid MA, Salum GM, El Awady MK.
J Interferon Cytokine Res. 2020 Oct;40(10):472-489. doi: 10.1089/jir.2020.0059. Epub 2020 Aug 25.
A review of hepatic fibrosis-associated histopathology in aged cadavers.
Mak KM, Kee D, Cheng CP.
Anat Rec (Hoboken). 2023 May;306(5):1031-1053. doi: 10.1002/ar.24931. Epub 2022 Apr 21.
Relaxin in hepatic fibrosis: What is known and where to head?
Ezhilarasan D.
Biochimie. 2021 Aug;187:144-151. doi: 10.1016/j.biochi.2021.06.001. Epub 2021 Jun 5.
Mangiferin relieves CCl4-induced liver fibrosis in mice.
Zhang L, Liu C, Yin L, Huang C, Fan S.
Sci Rep. 2023 Mar 13;13(1):4172. doi: 10.1038/s41598-023-30582-3.
Markers of hepatic fibrosis.
Caballería L, Torán P, Caballería J.
Med Clin (Barc). 2018 Apr 23;150(8):310-316. doi: 10.1016/j.medcli.2017.08.009. Epub 2017 Oct 18.
The non-invasive assessment of hepatic fibrosis.
Gheorghe G, Bungău S, Ceobanu G, Ilie M, Bacalbaşa N, Bratu OG, Vesa CM, Găman MA, Diaconu CC.
J Formos Med Assoc. 2021 Feb;120(2):794-803. doi: 10.1016/j.jfma.2020.08.019. Epub 2020 Aug 26.
